Advances in Parkinson's Disease

Advances in Parkinson's Disease

ISSN Print: 2169-9712
ISSN Online: 2169-9720
www.scirp.org/journal/apd
E-mail: apd@scirp.org
"Effectiveness of Istradefylline for Fatigue and Quality of Life in Parkinson’s Disease Patients’ and of Their Caregivers’"
written by Kazuo Abe, Masashi Fujita, Hiroo Yoshikawa,
published by Advances in Parkinson's Disease, Vol.5 No.2, 2016
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel …
Neurology and …, 2024
[2] Effort-related effects of chronic administration of the DA D2 receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co …
, 2023
[3] Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical Scenarios
Degenerative Neurological and …, 2022
[4] Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)
Parkinsonism & Related …, 2021
[5] Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson's disease
2021
[6] MEE Medical
2021
[7] Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
Frontiers in pharmacology, 2018
[8] Neurobiology and pharmacology of activational and effort-related aspects of motivation: rodent studies
Current Opinion in Behavioral Sciences, 2018
[9] The psychopharmacology of effort-related decision making: Dopamine, adenosine, and insights into the neurochemistry of motivation
2018
[10] New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders
2018
[11] New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease
Current Pharmacology Reports, 2016
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top